Updated on 4 September 2026
PVC 发泡板材、LVL 涂装型材及木塑制品出口供应服务
总经理 at 福建源锦新材料科技有限公司
China
About
一、企业概况
福建源锦新材料科技有限公司成立于 2020 年,位于福建南平,专注高分子新型环保材料研发、生产与出口,,年产能 2 万吨。获评福建省专精特新中小企业、通过三体系、SGS 等多项权威认证。
二、核心产品
主营 PVC 发泡板材 / 型材、LVL 涂装型材、PVC+LVL 复合型材、PE 复合木塑制品,兼具阻燃防潮、高韧性、高硬度等特性,适配建筑装饰、户外工程、整体家居等多场景,支持规格定制。
三、合作服务
建立全流程质量管控体系,设专项实验室全程检测,产品性能通过 SGS、Intertek 等国际机构测评。公司设国际营销中心,产品远销全球 20 余个国家和地区,面向一带一路沿线客户提供定制化产品与全链条出口配套服务。
Type
- Import & Export Solutions
Applies to
- South-East Asia
- East Asia
- Eastern Europe
Organisation
China
Similar opportunities
Project
- No
- No
- Manufacturing
- Bootstrapping
- Public Project
- Professional Services
- Partner Identification
- 5,000,001 to 7,500,000 USD
- 5,000,001 to 7,500,000 USD
曾 爱国
俄罗斯及独联体国家四川商会会长 at 中国西林集团有限公司/China Xilin Group.,Ltd
China
Project
- Yes
- Yes
- IPO
- Debt
- Livestock
- Bio-Tech
- Education
- Technology
- E-Business
- E-commerce
- IP Related
- Consultancy
- Shipbroking
- Tax Advisory
- Cargo Airline
- Biomass Energy
- Energy Storage
- Private Banking
- Health Facilities
- Digital Marketing
- Telecommunications
- Financial Services
- Resource Recycling
- Industry Solutions
- Financial Advisory
- Hydroelectric Energy
- Education Technology
- Open for negotiation
- Biometric Technology
- Open for Negotiation
- Professional Services
- Smart Card Technology
- Other Renewable Energy
- Advisory & Consultancy
- Requisition of Service
- Import & Export Solutions
- 7,500,001 to 10,000,000 USD
- 10,000,001 to 25,000,000 USD
- Risk Management & Resilience
- Information Technology Services
- Government-to-Government Project
- Investment / Financing Discussion
- Building And Construction Technology
- Environmental Management & Consultancy
- Agriculture, Food and Rural Development
一伯 刘
主席 at 华人华商联席会
China
Project
Human Respiratory Organoid Platform & Applications
- Yes
- Yes
- Equity
- Bio-Tech
- Technology
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Open for Negotiation
- Direct Equity Investment
- 5,000,001 to 7,500,000 USD
- 1,000,001 to 2,500,000 USD
- Government & Public Funding
- Private Equity & Venture Capital
- Investment / Financing Discussion
Roger Zhang
Commercial Director at Centre for Virology, Vaccinology and Therapeutics Limited
China (Hong Kong)